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ABSTRACT: There is an increasing realization that structure-based drug design may show improved success rates by understanding 
the ensemble of conformations and sub-states accessible to an enzyme and how the environment affects this ensemble. Human 
monoamine oxidase B (MAO-B) catalyzes the oxidation of amines and is inhibited for the treatment of both Parkinson’s disease and 
depression. Despite its clinical importance, its catalytic mechanism remains unclear and new routes to drugging this target would be 
valuable and relevant. Evidence of a radical in either the transition state or resting state of MAO-B is present throughout the literature, 
and is suggested to be a flavin semiquinone, a tyrosyl radical or both. Here we see evidence of a resting state flavin semiquinone, via 
absorption redox studies and electron paramagnetic resonance, suggesting that the anionic semiquinone is biologically relevant. Based 
on enzyme kinetic studies, enzyme variants and molecular dynamics simulations we find evidence for the crucial importance of the 
membrane environment in mediating the activity of MAO-B and that this mediation is related to effects on the protein dynamics of 
MAO-B. Further, our MD simulations identify a hitherto undescribed entrance for substrate binding, membrane modulated substrate 
access, and indications for half-site reactivity: only one active site is accessible to binding at a time. Our study therefore combines 
both experimental and computational evidence to illustrate the subtle interplay between enzyme activity, protein dynamics and the 
immediate membrane environment. Understanding key biomedical enzymes to this level of detail will be crucial to inform new 
strategies (and binding sites) for rational drug design for these drug targets.  
KEYWORDS EPR, Molecular Dynamics, Monoamine Oxidase B, semiquinone, enzyme, flavin, membrane 
Human monoamine Oxidase B (MAO-B) catalyzes the 
oxidative deamination of amines, by electron transfer, via its 
flavin adenine dinucleotide (FAD) cofactor (Scheme 1).1 It is 
located in the outer mitochondrial membrane,2 as a dimer, with 
bipartite substrate binding and active site cavities.1 MAO-B is 
the target of treatment for both depression and Parkinson’s 
disease, with inhibitors of the enzyme first being approved as 
pharmaceuticals in the 1960’s.3,4 
Despite the important medical applications associated with 
MAO-B its chemical mechanism remains unclear in the 
literature and there is debate over the role of MAO-B 
conformational change and protein dynamics. Reduction of the 
FAD has been shown to proceed by a tunneling mechanism via 
primary (1°) and secondary (2°) kinetic isotope effect (KIE) 
studies.5 These studies have suggested that MAO-B catalysis is 
not linked to fast (pico/nanosecond) dynamics.5,6 MAO-B 
catalysis has been investigated via experimental and 
computational studies, with at least seven different proposed 
mechanisms, including polar nucleophilic,7 radical,8 direct 
hydride transfer9–11 and two step hydride transfer12 (Scheme 
S1).  
Although the direct single electron transfer (SET) radical 
mechanism (Scheme S1) has previously been discounted 
experimentally13 and by quantum mechanics/molecular 
mechanics (QM/MM),14 a separate radical mechanism has been 
proposed by Murray et al.15 This was established via a model 
small molecule reaction that mimics MAO-B to provide 
evidence for a neutral semiquinone flavin that can be formed 
aerobically. The authors suggest that a neutral semiquinone 
flavin is the reactive species for the oxidation of benzylamine 
(BZA).15  This led to the hypothesis of a radical mechanism 
whereby MAO-B forms a neutral semiquinone flavin via a 
proximal tyrosine radical (Y398). The presence of a stable 
anionic semiquinone flavin and tyrosyl radical intermediate are 
also reported in MAO-A and MAO-N.16,17   
Scheme 1. General reaction catalyzed by MAO-B. 
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In our hands, we find spectroscopic evidence for a stable 
semiquinone in resting state MAO-B (vida infra). Here, MAO-
B was expressed and purified in Pichia pastoris as outlined by 
Newton-Vinson et al. 18  This protocol attributes observations 
of oxidized/semiquinone MAO-B FAD to reactive oxygen 
species (ROS) that form upon the disruption of the 
mitochondrial membrane, which they observe upon purification 
from bovine liver, but not from Pichia pastoris.18 
Previous observation of a stable anionic semiquinone FAD in 
MAO-B19,20 led to a hypothesis of half-site reactivity. This 
mechanism posits that one monomer of the MAO-B dimer is 
inaccessible to oxygen and substrate, resulting in the formation 
of the stable semiquinone species, whilst the other contains 
oxidized FAD. Electrons are then shuttled to the semiquinone 
species, allowing for the oxidation of the reduced FAD upon 
turnover.20 The authors suggest this might arise from electron 
shuttling between specific amino acids. Potentially such a 
mechanism might require significant conformational change 
associated with turnover in each monomer. Indeed, 
conformational changes have been found to be associated with 
MAO-B turnover, with a molecular dynamics (MD) study 
demonstrating the potential for the membrane to regulate access 
to the active site entrance via two gating loops (residues 85-119 
and 155-165).21 Other MD studies have been carried out on 
MAO-B, both with and without a membrane environment, with 
the focus on identifying or improving inhibitors for MAO-B22–
26, or ascertaining how MAO-B binds to the membrane.27 
Herein, we find evidence for the validity of a resting anionic 
semiquinone, and through kinetic and computational studies, 
evidence for conformationally controlled enzyme activity at 
each MAO-B monomer. Crucially, we find that the membrane 
environment is the arbiter of this control mechanism and 
exposes novel substrate/product channels that could be 
potential new drug targets. We thereby link the membrane 
environment, substrate binding and MAO-B conformational 
change to enzyme turnover. 
Results and Discussion 
Evidence for a resting-state semiquinone in MAO-B. The 
absorption spectrum of purified MAO-B is shown in Figure 1. 
The spectra are characteristic of an anionic semiquinone FAD 
(FAD‧-) with an absorption feature at ~415 nm.28 The 
preparation protocol of MAO-B was the same as that used by 
Newton-Vinson et al.,18 with small differences outlined in the 
materials and methods. Multiple preparations were completed, 
including the final polymer partition step outlined by Newton-
Vinson et al and without EDTA present, with the ~415 nm 
spectral feature consistently present in our hands. The effect of 
incubation with BZA, under anaerobic conditions, on the MAO-
B absorption feature at ~415 nm was monitored over time 
(Figure 1 inset).   From Figure 1 inset, we find a decrease in 
absorption at 415nm with respect to time on incubation with 
BZA, suggesting the ~415 nm spectral feature is redox sensitive 
with a natural MAO-B substrate.  
Potentially the ~415 nm absorption feature could be attributed 
to a tyrosyl radical, which has a characteristic absorbance peak 
at 410 nm,29 or a mixture of both an FAD semiquinone and 
tyrosyl radical, as seen as intermediates in MAO-A.16,17 Murray 
et al. postulated that the reactive semiquinone FAD was formed 
by a proximal tyrosyl radical (Y398). However, the UV-vis 
absorption spectrum of Y398F MAO-B shows the spectral 
feature at ~415 nm (Figure S1A), indicating that the observed 
spectral feature is not attributable to a Y398 tyrosyl radical. The 
Y398F variant also shows a slight increase in Km (Figure S2), 
similar in magnitude to previously reported changes in Km for 
Y398F.30  
To resolve this spectral feature, EPR was used on both wildtype 
(WT) and Y398F MAO-B. The X-band spectrum of the WT 
MAO-B immediately indicates that the signal arises from a  
Figure 1. The absorbance spectra of MAO-B after treatment with 
BZA over time. Inset, the effect on the 415 nm peak over time. 
Conditions, 40 mM BZA, 50 mM HEPES 0.5 % w/v Triton X-100, 
20 °C, anaerobic. 
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Figure 2. X-band cw-EPR spectra of WT (top, black) and 
Y398F (bottom, black) MAO-B, with their respective fitted 
simulations (red). EPR microwave frequency = 9.3916 GHz 
(WT) & 9.3926 GHz (Y398F), microwave power = 0.2 mW, 
modulation amplitude = 0.5 mT, temperature = 16 K. 
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semiquinone radical (Figure 2), in agreement with the UV-vis 
spectroscopy. The measured spectra lack the defining features 
which would identify the signal as arising from a tyrosyl 
radical:  the typical ‘wings’ or ‘shoulders’ around the central 
signal at around g = 2 16,31 at X-band (Figure 2), and increased 
g-value anisotropy at higher frequency (and therefore resonant 
field), i.e. Q-band (data not shown). Furthermore, the signal 
persists in the Y398F variant, confirming that it is not caused 
by the proximal tyrosine. 
Computational simulation and fitting of the experimental X-
band data of the WT and Y398F MAO-B (Table 1) suggests that 
the semiquinone radical species is anionic; the hyperfine 
environment of a neutral semiquinone radical would contain a 
contribution from an additional hydrogen atom.20,32 This is not 
the case for the signals seen in the X-band spectra. 
Previous studies have illustrated the importance of the 
membrane environment in mediating the normal enzymatic 
activity of MAO-B.21 To probe if the putative semiquinoid 
species (inferred from spectroscopic studies above) was also 
stably present in the membrane environment, we have 
conducted spectroscopic studies in an artificial membrane 
environment using l-α-phosphatidylcholine styrene maleic acid 
co-polymer (SMA) nanodiscs, prepared as reported 
previously.33 We find that the absorption feature at ~415 nm is 
present in both reduced triton X-100 and nanodisc 
environments (Figure S1A), implying that the putative anionic 
semiquinone is not an artifact of the buffer system used, and 
that its presence is not affected by the specific membrane 
environment used.  
Influence of the membrane environment on MAO-B turnover. 
To assess how/if the membrane environment affects enzyme 
turnover, we measured MAO-B turnover with both BZA and 
kynuramine dihydrobromide (KYN) at a range of temperatures. 
We monitor enzyme turnover based on the absorption features 
of benzaldehyde product formation at 250 nm for BZA,34 and 
4-hydroxyquinoline product formation at 316 nm for KYN.35 
This assay notionally primarily reflects the rate of reduction of 
the flavin.34 Our temperature dependence studies allow us to 
analyze not just the observed rate of enzyme turnover but also 
the thermodynamics of the system. The temperature-
dependence of the observed rate is shown in Figure 3. 
There has been a recent move to fitting enzyme temperature 
dependence data to physical models that allow for curvature in 
the associated plots. Such models often provide a more realistic 
fit to experimental data. We fit the MAO-B temperature 
dependence data to a model that incorporates the heat capacity 
of catalysis (Δ𝐶𝑃
‡
) (Eq 2) into the Eyring equation (Eq 1).36  
𝑘 = (
𝑘B𝑇
ℎ
) 𝑒
Δ𝑆‡
𝑅 𝑒−
Δ𝐻‡
𝑅𝑇      Eq 1 
𝑙𝑛𝑘 = 𝑙𝑛
𝑘𝐵𝑇
ℎ
− [
Δ𝐻𝑇0
‡ +Δ𝐶𝑃
‡(𝑇−𝑇0)
𝑅𝑇
] + [
Δ𝑆𝑇0
‡ +Δ𝐶𝑃
‡(𝑙𝑛𝑇−𝑙𝑛𝑇0)
𝑅
]  Eq 2 
Where ΔH‡ is the change in enthalpy and ΔS‡ is the change in 
entropy between the ground and transition state of the reaction 
at an arbitrary reference temperature (T0). This model has 
recently gained traction in studying enzyme temperature 
dependencies.37–40 Δ𝐶𝑃
‡
 quantifies the temperature dependence 
   WT MAO-B Y398F MAO-B 
g-tensor gx 2.00444 2.00444 
 gy 2.00429 2.00429 
 gz 2.00191 2.00191 
 giso 2.00355 2.00355 
A(14N) (MHz) A∥ 39.3 38.4 
 A⟂ 0 0 
A(14N) (MHz) A∥ 34.1 40.1 
 A⟂ 0 0 
Linewidth (mT) 1.1 1.1 
RMSD  0.0255 0.0440 
Table 1. Spectral parameters of EPR data extracted by 
simulation and fitting. 
Figure 3. The temperature dependence of MAO-B with BZA (A) and KYN (B) with reduced triton and nanodisc environments, fit to the 
MMRT equation. Conditions, 50 mM HEPES 0.5 % w/v reduced triton X-100. Reduced triton X-100: 1.5 mM BZA, 0.75 mM KYN. 
Nanodiscs: 3 mM BZA, 0.66 mM KYN. 
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of ΔH‡ and ΔS‡ and reflects the difference in the distribution 
and frequency of vibrational modes between the ground state 
and transition state.36,41 We have recently suggested that Δ𝐶𝑃
‡
 
can be used as a proxy for the changes in these vibrational 
modes during enzyme turnover and thus relates to some aspect 
of the protein’s molecular dynamics.38 This is relevant in the 
present study where the membrane environment may not alter 
the tertiary structure of the enzyme, but potentially alters 
protein fluctuations, which have previously been proposed to 
affect small molecule binding to the active site.21 
From Figure 3 and Table S1, we find Δ𝐶𝑃
‡
 to be the same within 
error for both KYN and BZA substrates when in a reduced triton 
X-100 environment. However, when in nanodiscs, the 
difference in Δ𝐶𝑃
‡
 for the different substrates is ΔΔ𝐶𝑃
‡
 = 2.4 ± 1.0 
kJ mol−1. The Δ𝐶𝑃
‡
 increases in magnitude from reduced triton 
to nanodiscs with KYN, and decreases with BZA (Figure 3). 
These data suggest that the difference in conformational 
fluctuations in the reactant and transition states changes are 
different in a more native membrane environment and for 
different substrates. Moreover, we find a significant difference 
in the observed rate of enzyme turnover in the nanodiscs (~5 
times faster). These data therefore provide experimental 
evidence of the notion that the membrane environment has a 
role in ‘tuning’ the molecular dynamics of MAO-B. However, 
given we observe a retention of the putative anionic flavin 
semiquinone, we would suggest the membrane does not affect 
the chemical mechanism of enzyme turnover per se.  
To investigate if perturbing the dynamics or flexibility of MAO-
B can lead to changes in turnover (as suggested by the 
difference in kinetics in reduced triton x-100 vs. nanodisc 
environment, see Figure 3), we have turned to computationally 
informed mutagenesis studies. We performed constraint 
analysis to identify both structural rigidity and the flexibility 
that permits large conformational changes,42 which may occur 
on the nanosecond to millisecond timescale.43 These 
calculations are based on an algorithm that defines a constraint-
network of movement for a protein, by analyzing and 
interpreting the limits of hydrogen bonds, hydrophobic relations 
and the angles and lengths of single and double covalent bonds. 
From this, the degrees of movement can be balanced against the 
constraints, leading to the overall rigidity of the protein being 
established.42  
By sequentially disregarding the side-chain contribution of 
MAO-B to its overall rigidity in the flexible motion calculations 
(see SI materials and methods), we identified residues that are 
likely to affect the flexibility of the enzyme. From these 
residues, we then selected three enzyme variants (W184F, 
E466Y and F402V) that, based on our calculations, were 
predicted to perturb the network of flexible motion, but are 
distal to the active site and catalytically relevant residues 
(Figure S3). We find that these variants retain the absorption 
feature at ~415 nm (Figure S1A) and their overall structure is 
not significantly perturbed, at least as assessed from their far-
UV circular dichroism spectra (Figure S1B). However, despite 
the variants being located a significant distance from the active 
site, we find that enzyme activity is ablated. Given that these 
variants are expected to alter the network of flexible motion, we 
suggest these data reflect the importance of protein 
conformational changes in MAO-B turnover. Such changes 
point to a potential rationale for the differences of our 
temperature dependence studies when MAO-B is in different 
environments. 
Computational evidence for a new entrance to the MAO-B 
active site mediated by the protein-membrane interaction. To 
obtain detailed insight into the role of the membrane 
environment on protein dynamics, we performed MD 
simulations of the MAO-B dimer embedded in a phospholipid 
membrane. We explore (i) the influence of the phospholipid 
membrane in modulating substrate/inhibitor binding, (ii) the 
accessibility of small molecules to the active site of MAO-B, 
and (iii) the potential for half-site reactivity, as discussed above. 
MD simulations of MAO-B in complex with FAD in a 
POPC/POPE lipid bilayer (similar to the native environment in 
the mitochondrial membrane)44 were performed in triplicate for 
150 ns in 3 different states: no BZA present (BZA0), one active 
site occupied with BZA (BZA1), and both active sites occupied 
with BZA (BZA2). Protein Cα RMSD and area per lipid head 
groups (Figure S4) indicated equilibration of both the protein 
and membrane after 50 ns of production MD. The analysis 
described below is therefore from 50 to 150 ns.  
Prior simulations of BZA0-MAO-B in a bilayer established that 
MAO-B ligand binding site access is modulated by the 
membrane.21 We investigate this further using longer 
simulations (150 ns vs. 50 ns) and with substrate (BZA) bound. 
To measure possible access to the substrate cavity of MAO-B 
via the membrane, we quantify the occurrence and features of 
tunnels in our simulations using Caver 3.0.45 Tunnels identified 
are grouped into clusters, allowing for the quantification of 
various characteristics, such as the frequency of occurrence and 
smallest width (bottleneck radius), as used here.46 This tool has 
previously been used to identify tunnels for ligand-induced 
protein flexibility analysis,47 to rationalize change in 
mechanism and kinetics of an enzyme upon a point mutation,48 
and to identify a tunnel to the FAD moiety in MAO-A.49  
Two main possible entrances for ligands into the MAO-B active 
site are found at either side of the gating loop residues 99 to 112 
(Figure 4). Entrance A (Figure 4A) is accessed via the 
membrane and its opening has previously been observed.21 
Briefly, a π-π stacking interaction between Tyr97 and Trp107 is 
lost as Trp107 buries into the aliphatic lipid tails of the bilayer, 
establishing an additional interaction of MAO-B with the 
phospholipid bilayer.  
Entrance B (Figure 4B) is solvent accessible, and its opening is 
controlled by the conformation of three loop regions (81 to 88, 
99 to 112 and 198 to 208). To the best of our knowledge, its 
opening has not yet been observed through protein 
crystallography or simulation. To provide a qualitative 
description of the open and closed conformations of this 
entrance, we have performed clustering analysis on the entrance 
loop residues (see Materials and Methods). Opening of 
Entrance B (Figure S5 A,B) can be described by: 1) loop 81-88 
separates from loop 199-206, breaking a number of transiently 
formed electrostatic interactions and instead forming 
interactions with the solvent in the open conformation; 2) the 
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central region of the gating loop (residues P102, F103, P104) 
rotates down and away from the hydrophobic core of the 
entrance cavity. The opening of both entrance A and B involves 
residues directly interacting with the bilayer.  This indicates that 
the membrane is important in modulating access to the substrate 
binding pocket of MAO-B. 
Evidence of asymmetry in MAO-B from MD simulation. 
Previous studies have suggested that the presence of an anionic 
semiquinone could be mechanistically significant as part of a 
half-site reactivity mechanism.20 To investigate the potential for 
half-site reactivity in MAO-B, tunnels from the N5 of the flavin 
to the solvent were first identified from all MD trajectories with 
BZA0, BZA1 and BZA2 (with three replicates). These data are 
useful to determine the size of species that could access the 
active site and to investigate whether access to the active site is 
half-site specific. To avoid identifying numerous tunnels that 
cannot accommodate substrate/product molecules, a minimum 
tunnel radius was set to 1.5 Å. (This avoids identifying water 
tunnels, as water has a Van der Waals radius of ~1.4 Å.50) With 
this criterion, no tunnels were found, which demonstrates a 
closed active-site on the timescales of our simulations. Whilst 
larger conformational changes may be occurring on longer 
time-scales (or in presence of substrate in the vicinity of a 
bottleneck) to enable substrate access to the active site, a 
generally closed off active site is in agreement with previous 
experimental findings.20  
Next, tunnels were identified from the substrate binding cavity 
towards the protein surface. The starting point was defined as 
the center of mass between the alpha carbon (Cα) atoms of 
residues 168 and 316 (Figure S6). This starting point was 
chosen as it is located within the substrate binding cavity and is 
common to both previously described substrate entrance 
tunnels (Figure 4). Tunnel frequency and the average bottleneck 
radius of all tunnels identified in both monomers were obtained 
for BZA0 and BZA1 (Figure 5 A,B).  To aid discussion, we 
designate each monomer as monomer 1 or monomer 2, noting 
that this does not imply a structural or other difference between 
monomers. 
Figure 4. MAO-B in POPC/POPE membrane environment. The substrate binding area is shown in light green and light blue (residues 
80-210, 286-390, and 454-488). The active site area is shown in dark green and dark blue (residues 4-79, 211-285, and 391-435). The 
membrane binding region is shown in red (residues 489-500). The binding site gating loop is shown in black (residues 99-122). The 
navy spheres on the left and the right are the two main entrances (or tunnels) to the binding site (as identified by Caver 3.0 45). Entrance 
B is newly identified here, Entrance A has been previously described.21 
A B 
Figure 5. A. The summed tunnel frequency from the substrate binding site of MAO-B to solvent, identified by caver. BZA0 – No BZA is 
bound in either monomer. BZA1 – BZA is bound only in monomer 1. All are from triplicate MD runs. B. The average maximum bottleneck 
(Å) from substrate binding site of MAO-B to solvent, identified by caver. Same conditions as panel A.  
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Notably, both the frequency and maximum bottleneck radius of 
tunnels to the substrate binding cavity of MAO-B is 
significantly different for each monomer. In the absence of 
BZA, monomer 1 presents a higher frequency of tunnels, with 
a larger average maximum bottleneck radius. When BZA is 
present in its catalytically competent conformation in monomer 
1 and not monomer 2, the frequency of tunnels and maximum 
bottleneck measurements are higher for monomer 2 (Figure 
5A,B, Figure 6 and Table S2). At Figure 6 the different colours 
show different routes from the starting point to the solvent, with 
the majority of tunnels passing the aforementioned entrances A 
and B (Figure 4). Asymmetry between the monomers was also 
observed in the flexibility of the binding site gating loop 
(residues 95-115): it was found to be significantly more flexible 
in the BZA1-unbound monomer than in the BZA1-bound and BZA0 
monomers (Figure S7).  
The observed ‘closing’ of the active site entrance in the BZA1-
bound monomer and ‘opening’ in the BZA1-unbound monomer are 
particularly notable. This indicates that when BZA is bound to 
the active site cavity of one monomer, a subsequent BZA is 
more likely to enter the binding site of the opposite monomer. 
Such asymmetry may prevent binding of subsequent BZA into 
the same monomer, allowing for the release of products, whilst 
increasing the efficiency of binding in the opposite ‘free’ 
monomer. Previous experimental work indicated that binding 
of inhibitor to the intermediate binding site of MAO-B was 
increased where inhibitor was already bound into the active site 
(see Figure 4 for binding/active site differentiation).51 Whilst it 
is not known whether this is within the same monomer, it could 
explain the asymmetry in binding site access seen here when 
BZA1 is present.  
BZA2 was not considered for half-site reactivity analysis. This 
was due to BZA leaving the active site altogether in one 
simulation trajectory (Figure S8), meaning that the identified 
tunnels would not be comparable to those where BZA does not 
leave. This BZA movement may indicate, however, that BZA2 
is potentially an unstable configuration, providing further 
evidence towards asymmetry in MAO-B.  
Conclusions 
MAO-B is an important biomedical target, and as with many 
such targets, is associated with a biological membrane. Such 
association places enzymes in specific physiological contexts, 
can promote interaction with other species and enable specific 
structural features. Less obvious is the role of the membrane 
environment in mediating the conformational dynamics of 
enzymes, and whether this is functionally important.  
Previous molecular dynamics studies have illustrated that the 
immediate membrane environment of MAO-B is involved in 
controlling substrate entrance to channels leading to the active 
site. Here, using enzyme kinetic and mutagenesis studies, we 
consider the role of the membrane environment in tuning the 
molecular dynamics of MAO-B more widely, including its 
influence on turnover and catalysis. We find that placement of 
MAO-B in SMA nanodiscs instead of in reduced triton X-100 
has a significant effect on the heat capacity of catalysis (Δ𝐶𝑃
‡
). 
Differences in Δ𝐶𝑃
‡
 reflect differences in the distribution and 
Monomer 1 Monomer 2 Monomer 1 Monomer 2 
A B 
Figure 6. All tunnels identified by caver over all three MD simulation repeats, for the binding site of MAO-B, with FAD cofactor shown as 
yellow sticks. A. Without substrate bound (BZA0). B. With BZA in monomer 1 (shown as red sticks), and not monomer 2 (BZA1).  
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frequency of vibrational modes between the ground (reactant) 
and transition states and implies that the membrane 
environment is affecting the global protein dynamics of MAO-
B and that these dynamics influence the thermodynamics of 
enzyme turnover. Indeed, kcat is ~5 times faster in the nanodisc 
environment versus reduced triton X-100. These data further 
hint at the role of the specific lipid composition and fine 
structure of the membrane to tune MAO-B turnover efficiency. 
These findings are corroborated by studying enzyme variants 
that are predicted to alter the network of flexible motion in the 
enzyme, but do not affect the overall structure. These variants, 
which are distal to the active site, all lead to inactive enzyme, 
indicating the critical role of ‘optimized’ global protein 
dynamics of MAO-B.  
Through atomistic molecular dynamics simulations with and 
without substrate bound, we find two substrate entrance/product 
exit channels that are mediated by membrane interaction, one 
of which was not previously described.  The simulations further 
indicate an asymmetry in substrate access in the MOA-B dimer. 
Specifically, either one or the other monomer may allow 
substrate access at any one time, with active site occupation in 
one monomer preferentially allowing substrate access to the 
other. 
Taken together, our study suggests that the global protein 
dynamics of MAO-B are ‘tuned’ by the specific immediate 
membrane environment. These protein dynamics have a major 
effect on MAO-B function, through tuning fluctuations linked 
to enzyme turnover, but also in controlling the opening and 
closing of substrate/product channels. The finding that two 
different channels mediated by the membrane environment are 
present in MAO-B illustrates the potential to exploit novel small 
molecule binding sites with rational drug design. That is, our 
study illustrates that when searching for novel small molecule 
binding sites one should consider not just static structure and 
the experimental system in isolation, but time-dependent 
changes in the population of conformational sub-states and in 
the ‘native’ environment. 
Experimental materials and methods  
Unless otherwise stated, all reagents were obtained from Sigma-
Aldrich.  
MAO-B expression and purification. MAO-B was expressed 
and purified following the purification protocol by Newton-
Vinson et al.18 Small variations from the protocol include shake 
flask fermentation instead of bioreactor fermentation, with 
BMMY (buffered methanol-complex medium) media instead of 
MM (minimal methanol) media for induction, storage of cell 
pellets in a buffer with protease inhibitor tablets instead of 
PMSF, suspension of pellet in 100 ml of breaking buffer instead 
of 1 L, and cell breakage of 30 s on 30 s off x 10 sonication in 
addition to bead beating.  The purification was completed after 
MAO-B was passed over a DEAE-sepharose FF column, 
achieving satisfactory purity. The additional polymer partition 
step detailed by Newton-Vinson et al.18 did not change the state 
of the semiquinone MAO-B species seen here, with additional 
purity achieved by size exclusion chromatography if necessary. 
Nanodisc preparation. Nanodiscs were prepared following 
methods by McDowall et al.,33 suspended in 50 mM HEPES, 
pH 7.5. and incubated with MAO-B in a 10x molar excess, for 
2 hours prior to experiments.  
Enzyme assays. MAO-B was transferred from Triton X-100 
containing buffer to reduced triton X-100 or nanodisc 
containing buffer using detergent removal spin columns 
(Thermo Scientific Pierce).  Steady-state MAO-B kinetic 
measurements were carried out using a 1 ml quartz cuvette and 
a UV⁄ Vis spectro-photometer (Agilent Cary 60 UV-Vis 
spectrometer) in 50 mM HEPES (pH 7.5), containing 0.5 % 
(w/v) reduced Triton X-100 or SMA l-α-Phosphatidylcholine 
nanodiscs. Enzyme activity was measured by following the 
formation of benzaldehyde using ε250 = 12,800 M−1 cm−1 for 
BZA,34 and 4-hydroxyquinoline using ε316 = 12,300 M−1 cm−1  
for KYN.35  For each condition substrate dependences were 
monitored at 40 °C ; the data fitted well to Michaelis-Menten 
kinetics (Figure S9).   Temperature dependences were carried 
out from 20 °C - 45 °C at 5 °C intervals using initial velocity 
measurements at substrate concentrations maintained above 
10x Km to ensure saturation. The data were fitted to Eq 2 as 
described in the manuscript using OriginPro 2017.  
Redox assays. These experiments were performed 
anaerobically, all buffer was purged with nitrogen and samples 
were prepared in an anaerobic box. Glucose and glucose 
oxidase were added to maintain anaerobic conditions.  
EPR. Measurements were performed using WT and Y398F 
variant MAO-B in 50 mM HEPES 0.5% Triton, pH 7.5, flash-
frozen in liquid nitrogen in suprasil quartz sample tubes. X-
band cw-EPR spectra were recorded on a Bruker eleXsys E500 
spectrometer using a standard rectangular Bruker EPR cavity 
(ER4102T) equipped with an Oxford helium cryostat 
(ESR900). Experimental parameters: microwave power, 
0.2 mW; field modulation amplitude, 5 G; field modulation 
frequency, 100 kHz; measuring time 10 s; temperature 16 K. Q-
band cw-EPR spectra were performed on a Bruker eleXsys E-
560 spectrometer using a ER 5106QT-W1 resonator equipped 
with a home-built ARS cryogen-free cryostat (data not shown). 
Spectral simulations were performed using the Matlab-based 
Easyspin package.52 
Computational materials and methods. The X-ray crystal 
structure of MAO-B in complex with 6-hydroxy-N-propargyl-
1(R)-aminoindan (1S3E)53 was used as the starting point for all 
MD simulations. The missing C-terminal residues (502 – 520 
Chain A and 497 – 520 Chain B) which form the remainder of 
the transmembrane helix were built using Avogadro54 
(assuming the standard backbone dihedral angles of an α-helix). 
MAO-B was then inserted into a lipid bilayer comprised of a 
4:3 ratio of palmitoyloleoylphosphatidylcholine (POPC) and 
palmitoyloleoyl-phosphatidylethanolamine (POPE) using 
CHARMM-GUI.55 This composition has been used in prior 
bilayer MD simulations of MAO-B, and was chosen to 
represent the composition of the outer mitochondrial 
membrane.21,27,44 BZA was placed in the active site by 
alignment with the crystal structure of MAO-B in complex with 
nitrobenzylamine (2C70,56 Cα RMSD 0.118 Å to 1S3E; the 
latter was used due to its higher resolution). All simulations of 
8 
 
BZA were performed with the amino group in its neutral form, 
as this is widely believed to be the catalytically competent state 
of BZA.13,14,57 Titratable residues were simulated in their 
standard protonation states, based on calculations with PropKa 
3.058. MolProbity was used to determine the optimum 
tautomerisation states of every His residue, and any required 
Asn/Gln side chain flips, based on optimizing the hydrogen 
bonding network59. Histidines 91, 115 and 452 were singly 
protonated on their Nδ1, with all others singly protonated on 
their Nε2. The system was then solvated such that there was no 
protein or lipid atom within 20 Å of the edge of the periodic box 
along the z-coordinate (bilayer normal). The total number of 
atoms for each system simulated was approximately 90,000. 
Periodic boundary simulations were performed with Amber16, 
using the CHARMM36 force field to describe protein60 and 
lipid61 atoms, and TIP3P for water. Parameters for FAD in its 
oxidized form and BZA in its neutral form were taken from 
Abad et al.14 Following minimization, heating and equilibration 
(see SI Materials and Methods), production MD simulations 
were run in the NpT ensemble at 310 K, with semi-isotropic 
coupling to a Monte Carlo barostat. Temperature was regulated 
using Langevin dynamics with a collision frequency of 1 ps−1. 
A time step of 2 fs was applied with the covalent bonds to 
hydrogen constrained by the SHAKE algorithm. A 12 Å non-
bonded cut-off was applied with a force switch smoothing 
function from 10 to 12 Å. Long range electrostatics were 
evaluated with the particle mesh Ewald method.62 A total of 9 
simulations were performed for 150 ns each, with the first 50 ns 
of simulation used as equilibration. The BZA2 run in which a 
BZA escapes the active site cavity was extended for a further 
50 ns. Coordinates were saved every 10 ps for further analysis. 
Routine analysis of trajectories was performed using cpptraj  
from the AmberTools suite.63 Area per lipid calculations were 
performed with GridMAT-MD,64 using a grid resolution of 200 
x 200 points for each measurement. Tunnel analysis was 
performed with Caver 3.045. All settings were kept default apart 
from bottleneck radius (1.5 Å).  
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